Rises in Hematocrit Are Associated With an Increased Risk of Major Adverse Cardiovascular Events in Men Starting Testosterone Therapy: A Retrospective Cohort Claims Database Analysis.

Kohn, Taylor P; Agrawal, Pranjal; Ory, Jesse; Hare, Joshua M; Ramasamy, Ranjith

Kohn, Taylor P; Agrawal, Pranjal; Ory, Jesse; Hare, Joshua M; Ramasamy, Ranjith.

Afiliação

Kohn TP; The James Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Agrawal P; The James Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Ory J; Department of Urology, Dalhousie University, Halifax, Nova Scotia, Canada.
Hare JM; The Interdisciplinary Stem Cell Institute and Department of Medicine, University of Miami Miller School of Medicine, Miami, Florida.
Ramasamy R; Desai Sethi Urological Institute, Miller School of Medicine, University of Miami, Miami, Florida.

J Urol ; 211(2): 285-293, 2024 Feb.

Article em En | MEDLINE | ID: mdl-37948758

Assuntos

Infarto do Miocárdio; Acidente Vascular Cerebral; Masculino; Humanos; Adulto; Pessoa de Meia-Idade; Testosterona/efeitos adversos; Estudos Retrospectivos; Hematócrito; Infarto do Miocárdio/induzido quimicamente; Infarto do Miocárdio/epidemiologia; Acidente Vascular Cerebral/induzido quimicamente

Palavras-chave

death; hematocrit; ischemic stroke; myocardial infarction; testosterone

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Acidente Vascular Cerebral / Infarto do Miocárdio Limite: Adult / Humans / Male / Middle aged Idioma: En Revista: J Urol Ano de publicação: 2024 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google